CDKN2A and acute lymphoblastic leukemia: However, when analyzing the genetic deletion of CDKN2, a common B-ALL feature, it was found that patients with the wild-type CDKN2 experienced a higher rate of MYC-IGH translocation [51], suggesting that the two genetic alterations may be mutually exclusive.